Hansoh Pharmaceutical Group revenue and financials
In the fiscal year ended December 2025, Hansoh Pharmaceutical Group reported revenue of ¥15.03B (+22.57% year over year). Net income was ¥5.56B, a net margin of 37.0%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +22.57%
- 2025 vs 2024
- Net income growth
- +27.07%
- 2025 vs 2024
- Net margin
- 37.0%
- 2024: 35.7%
How Hansoh Pharmaceutical Group is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 11.6% a year on average over the last 5 years
Compound annual growth rate: from ¥8.69B in 2020 to ¥15.03B in 2025.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 27.8% to 35.9%
Operating income over revenue, 2022 → 2025: 8.1 percentage points.
Profits turn into cash: free cash flow equal to 98% of net income
Totals for fiscal years 2023–2025: free cash flow ¥12.92B, net income ¥13.2B.
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15,028 | 12,261 | 10,104 | 9,382 | 9,935 | 8,690 | 8,683 | 7,722 | 6,186 | 5,433 |
| Cost of revenue | 1,519 | 1,117 | 1,033 | 870 | 870 | 803 | 738 | 603 | 455 | 397 |
| Gross profit | 13,509 | 11,144 | 9,071 | 8,512 | 9,065 | 7,887 | 7,945 | 7,119 | 5,730 | 5,036 |
| Selling, general and administrative | 4,736 | 4,508 | 4,241 | 4,148 | 4,371 | 3,862 | 4,044 | 3,999 | 3,318 | 2,916 |
| Research and development | 3,358 | 2,702 | 2,097 | 1,693 | 1,797 | 1,252 | 1,121 | 881 | 576 | 403 |
| Operating income | 5,401 | 3,902 | 2,679 | 2,607 | 2,821 | 2,773 | 2,780 | 2,239 | 1,837 | 1,717 |
| EBIT | 5,401 | 3,902 | 2,679 | 2,607 | 2,821 | 2,773 | 2,780 | 2,239 | 1,837 | 1,717 |
| EBITDA | 5,764 | 4,278 | 3,025 | 2,932 | 3,084 | 2,989 | 2,964 | 2,388 | 1,968 | 1,832 |
| Interest expense | 3.2 | 6.7 | 66.7 | 58.1 | 52.8 | 1.6 | 0.1 | — | — | 3.4 |
| Pre-tax income | 6,551 | 5,085 | 3,766 | 2,948 | 3,300 | 3,098 | 3,001 | 2,309 | 1,933 | 1,804 |
| Income tax | 995 | 713 | 489 | 365 | 587 | 529 | 444 | 406 | 337 | 328 |
| Net income | 5,555 | 4,372 | 3,278 | 2,584 | 2,713 | 2,569 | 2,557 | 1,903 | 1,595 | 1,476 |
| Net income to common shareholders | 5,555 | 4,372 | 3,278 | 2,584 | 2,713 | 2,569 | 2,557 | 1,903 | 1,595 | 1,476 |
| Basic EPS | 0.93 | 0.74 | 0.55 | 0.44 | 0.46 | 0.44 | 0.47 | 0.38 | — | — |
| Diluted EPS | 0.93 | 0.73 | 0.52 | 0.44 | 0.44 | 0.44 | 0.47 | 0.38 | — | — |
| Average shares (basic) | 5,963 | 5,930 | 5,925 | 5,916 | 5,921 | 5,876 | 5,477 | 5,000 | — | — |
| Average shares (diluted) | 5,981 | 5,950 | 6,020 | 5,929 | 5,998 | 5,878 | 5,477 | 5,000 | — | — |
| Dividend per share | 0.39 | 0.32 | 0.19 | 0.09 | 0.07 | 0.07 | — | — | — | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8,304 | 7,595 | 7,434 | 5,755 | 6,506 | 5,593 | 4,511 | 4,948 | 4,434 | 5,534 |
| Cost of revenue | 674 | 842 | 677 | 531 | 586 | 501 | 531 | 471 | 399 | 454 |
| Gross profit | 7,630 | 6,753 | 6,756 | 5,225 | 5,920 | 5,091 | 3,980 | 4,477 | 4,035 | 5,080 |
| Selling, general and administrative | 2,187 | 2,575 | 2,161 | 2,434 | 2,075 | 2,241 | 2,000 | 2,172 | 1,975 | 2,409 |
| Research and development | 1,739 | 1,917 | 1,441 | 1,505 | 1,196 | 1,168 | 929 | 954 | 739 | 1,110 |
| Operating income | 3,685 | 2,248 | 3,154 | 1,305 | 2,597 | 1,644 | 1,035 | 1,378 | 1,230 | 1,440 |
| EBIT | 3,685 | 2,248 | 3,154 | 1,305 | 2,597 | 1,644 | 1,035 | 1,378 | 1,230 | 1,440 |
| EBITDA | 3,867 | 2,427 | 3,337 | 1,476 | 2,802 | 1,815 | 1,210 | 1,554 | 1,378 | 1,579 |
| Interest expense | 48.6 | 1.5 | 1.6 | 1.7 | 4.9 | 35.9 | 30.7 | 29.5 | 28.7 | 25.7 |
| Pre-tax income | 5,009 | 2,862 | 3,688 | 1,967 | 3,118 | 2,266 | 1,500 | 1,439 | 1,509 | 1,753 |
| Income tax | 751 | 442 | 553 | 321 | 393 | 278 | 211 | 154 | 211 | 331 |
| Net income | 4,258 | 2,421 | 3,135 | 1,646 | 2,726 | 1,989 | 1,289 | 1,286 | 1,298 | 1,422 |
| Net income to common shareholders | 4,258 | 2,421 | 3,135 | 1,646 | 2,726 | 1,989 | 1,289 | 1,286 | 1,298 | 1,422 |
| Basic EPS | 0.70 | 0.40 | 0.53 | 0.28 | 0.46 | 0.34 | 0.22 | 0.22 | 0.22 | 0.24 |
| Diluted EPS | 0.70 | 0.40 | 0.53 | 0.28 | 0.46 | 0.30 | 0.22 | 0.22 | 0.22 | 0.24 |
| Average shares (basic) | 6,057 | 5,988 | 5,938 | 5,934 | 5,926 | 5,926 | 5,924 | 5,915 | 5,917 | 5,922 |
| Average shares (diluted) | 6,138 | 6,005 | 5,956 | 5,953 | 5,947 | 6,096 | 5,944 | 5,939 | 5,919 | 6,003 |
| Dividend per share | 0.25 | 0.18 | 0.21 | 0.13 | 0.19 | 0.13 | 0.07 | 0.05 | 0.04 | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 39,900 | 31,658 | 33,039 | 30,002 | 27,160 | 20,792 | 19,575 | 8,414 | 5,874 | 4,821 |
| Current assets | 35,555 | 27,442 | 28,883 | 25,832 | 23,179 | 17,286 | 17,448 | 6,684 | 4,418 | 3,464 |
| Cash and equivalents | 31,549 | 22,622 | 22,435 | 17,615 | 14,702 | 4,285 | 8,238 | 965 | 266 | 209 |
| Short-term investments | 8.2 | 780 | 1,937 | 1,471 | 1,882 | 9,241 | 3,588 | 515 | 869 | 877 |
| Receivables | 3,246 | 3,264 | 3,295 | 3,626 | 3,729 | 3,210 | 2,279 | 2,674 | 2,213 | 1,740 |
| Inventory | 609 | 651 | 576 | 448 | 410 | 299 | 414 | 480 | 439 | 353 |
| Net property, plant and equipment | 3,179 | 3,247 | 3,280 | 3,450 | 3,475 | 2,304 | 1,928 | 1,382 | 1,171 | 1,048 |
| Other intangible assets | 363 | 245 | 177 | 33.4 | 17.0 | 9.9 | 4.6 | 10.5 | 9.2 | 6.1 |
| Long-term investments | 772 | 702 | 685 | 654 | 395 | 28.4 | — | — | — | — |
| Current liabilities | 4,395 | 2,695 | 6,863 | 2,620 | 3,024 | 2,690 | 6,240 | 4,504 | 1,228 | 1,812 |
| Accounts payable | 334 | 218 | 164 | 222 | 248 | 124 | 193 | 159 | 98.8 | 44.9 |
| Long-term debt | — | 0.0 | 39.7 | 4,283 | 3,743 | — | — | — | — | — |
| Total debt | 105 | 118 | 4,304 | 4,378 | 3,828 | 92.7 | 9.4 | — | — | — |
| Total liabilities | 4,536 | 2,978 | 7,244 | 7,355 | 7,131 | 2,916 | 6,531 | 5,946 | 1,355 | 1,847 |
| Total equity (incl. minority) | 35,364 | 28,680 | 25,795 | 22,647 | 20,029 | 17,876 | 13,044 | 2,468 | 4,519 | 2,974 |
| Retained earnings | 17,461 | 13,918 | 11,405 | 8,780 | 6,910 | 4,578 | 2,009 | 1,152 | 3,249 | 1,654 |
| Minority interest | — | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 46,605 | 39,900 | 35,071 | 31,658 | 31,672 | 33,039 | 31,942 | 30,002 | 28,845 | 27,160 |
| Current assets | 41,458 | 35,555 | 30,819 | 27,442 | 27,406 | 28,883 | 27,751 | 25,832 | 24,697 | 23,179 |
| Cash and equivalents | 37,383 | 31,549 | 27,104 | 22,622 | 21,745 | 22,435 | 16,917 | 17,615 | 16,978 | 14,702 |
| Short-term investments | — | 8.2 | 17.6 | 780 | 1,431 | 1,937 | 2,089 | 1,471 | 2,086 | 1,882 |
| Receivables | 3,156 | 3,246 | 2,794 | 3,264 | 2,938 | 3,295 | 3,327 | 3,626 | 3,033 | 3,729 |
| Inventory | 686 | 609 | 653 | 651 | 600 | 576 | 600 | 448 | 497 | 410 |
| Net property, plant and equipment | 3,260 | 3,179 | 3,203 | 3,247 | 3,308 | 3,280 | 3,369 | 3,450 | 3,505 | 3,475 |
| Other intangible assets | 482 | 363 | 289 | 245 | 197 | 177 | 132 | 33.4 | 31.8 | 17.0 |
| Long-term investments | 1,327 | 772 | 733 | 702 | 743 | 685 | 677 | 654 | 525 | 395 |
| Current liabilities | 8,490 | 4,395 | 3,601 | 2,695 | 3,433 | 6,863 | 7,416 | 2,620 | 3,208 | 3,024 |
| Accounts payable | 377 | 334 | 269 | 218 | 175 | 164 | 298 | 222 | 240 | 248 |
| Long-term debt | — | — | — | — | — | 39.7 | — | 4,283 | 4,030 | 3,743 |
| Total debt | 4,234 | 105 | 117 | 118 | 120 | 4,304 | 4,554 | 4,378 | 4,130 | 3,828 |
| Total liabilities | 8,837 | 4,536 | 3,975 | 2,978 | 3,769 | 7,244 | 7,767 | 7,355 | 7,719 | 7,131 |
| Total equity (incl. minority) | 37,768 | 35,364 | 31,097 | 28,680 | 27,903 | 25,795 | 24,176 | 22,647 | 21,126 | 20,029 |
| Retained earnings | 20,664 | 17,461 | 16,318 | 13,918 | 13,362 | 11,405 | 9,800 | 8,780 | 7,752 | 6,910 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 6,738 | 3,862 | 3,116 | 2,741 | 2,577 | 2,390 | 3,330 | 2,072 | 1,402 | 1,247 |
| Depreciation and amortization | 391 | 401 | 366 | 345 | 278 | 228 | 190 | 149 | 131 | 115 |
| Capital expenditure | -356 | -222 | -220 | -273 | -460 | -1,428 | -592 | -381 | -256 | -239 |
| Investing cash flow | -7,155 | -1,392 | 1,074 | -5,935 | -2,259 | -2,874 | -7,076 | -1,389 | -614 | 830 |
| Financing cash flow | 1,554 | -6,066 | -754 | -818 | 3,417 | -1,036 | 7,993 | — | -730 | -2,049 |
| Dividends paid | -2,012 | -1,858 | -652 | -712 | -381 | -4,200 | -1,500 | — | -404 | -2,279 |
| Share repurchases | — | -33.7 | -115 | -76.6 | -58.0 | — | — | — | — | — |
| Debt issued | 0.0 | 500 | 900 | 0.0 | 3,877 | — | — | — | — | 400 |
| Debt repaid | -22.4 | -4,704 | -919 | -42.5 | -12.3 | -7.6 | -41.7 | — | — | -450 |
| Effect of exchange rates | -51.6 | -62.4 | -122 | -40.6 | -79.3 | -762 | 133 | 14.9 | 0.2 | 20.0 |
| Net change in cash | 1,086 | -3,658 | 3,314 | -4,053 | 3,655 | -2,282 | 4,380 | 698 | 57.7 | 47.5 |
| Free cash flow | 6,382 | 3,640 | 2,897 | 2,468 | 2,117 | — | — | — | — | — |
| Levered free cash flow | 5,162 | 2,401 | 2,069 | 1,453 | 1,256 | -3,674 | 3,413 | 3,939 | -127 | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2,337 | 3,133 | 3,605 | 1,180 | 2,682 | 1,970 | 1,146 | 967 | 1,774 | 1,493 |
| Depreciation and amortization | 197 | 194 | 197 | 185 | 217 | 182 | 185 | 186 | 158 | 146 |
| Capital expenditure | -251 | -183 | -173 | -120 | -102 | -127 | -92.6 | -86.9 | -186 | -208 |
| Investing cash flow | -5,048 | -5,649 | -1,506 | -3,761 | 2,369 | 32.1 | 1,042 | -467 | -5,468 | -2,680 |
| Financing cash flow | 4,103 | 1,534 | 20.0 | -1,870 | -4,196 | -703 | -50.5 | -763 | -54.8 | -379 |
| Dividends paid | — | -2,012 | — | -1,858 | — | -652 | — | -712 | — | -317 |
| Share repurchases | -12.7 | — | — | 0.0 | -33.7 | -35.4 | -79.5 | -18.6 | -58.1 | -58.0 |
| Debt issued | 4,137 | — | — | 0.0 | 500 | 900 | — | — | — | 24.2 |
| Debt repaid | -49.1 | -11.3 | -11.1 | -11.3 | -4,693 | -910 | -9.0 | -35.0 | -7.5 | -4.3 |
| Effect of exchange rates | -145 | -46.3 | -5.2 | -23.2 | -39.2 | -50.0 | -72.4 | 221 | -262 | -368 |
| Net change in cash | 1,248 | -1,029 | 2,115 | -4,474 | 816 | 1,249 | 2,065 | -41.4 | -4,011 | -1,934 |
| Free cash flow | 2,087 | 2,950 | 3,432 | 1,060 | 2,581 | 1,843 | 1,054 | 880 | 1,588 | 1,285 |
| Levered free cash flow | 2,105 | 1,913 | 3,249 | 39.8 | 2,361 | 1,047 | 1,022 | 28.8 | 1,424 | 598 |
Financial statements of similar companies
Companies in the group: same industry, similar size
